Short Interest in Medios AG (OTCMKTS:MEDOF) Drops By 63.9%

Medios AG (OTCMKTS:MEDOFGet Free Report) was the target of a large decline in short interest in May. As of May 29th, there was short interest totaling 694 shares, a decline of 63.9% from the May 14th total of 1,924 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Medios Stock Performance

Shares of OTCMKTS:MEDOF remained flat at C$13.64 during trading hours on Friday. Medios has a 1 year low of C$13.64 and a 1 year high of C$13.64. The business’s 50-day moving average is C$13.64 and its two-hundred day moving average is C$13.64.

Medios Company Profile

(Get Free Report)

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic infusion preparations, antibody therapies, virostatic and antibiotic medications, parenteral nutrition solutions, and investigational medicinal products.

Featured Stories

Receive News & Ratings for Medios Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medios and related companies with MarketBeat.com's FREE daily email newsletter.